Sharma Amit is Director of Checkpoint Therapeutics, Inc.. Currently has a direct ownership of 0 shares of CKPT, which is worth approximately $0. The most recent transaction as insider was on May 30, 2025, when has been sold 94,246 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

Sharma Amit Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 30 2025
SELL
Disposition due to a tender of shares in a change of control transaction
-
94,246 Reduced 100.0%
0 Common Stock
May 28 2025
BUY
Grant, award, or other acquisition
-
12,195 Added 11.46%
94,246 Common Stock
May 14 2024
BUY
Grant, award, or other acquisition
-
32,051 Added 28.09%
82,051 Common Stock
SA

Sharma Amit

Director
Waltham, MA

Track Institutional and Insider Activities on CKPT

Follow Checkpoint Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CKPT shares.

Notify only if

Insider Trading

Get notified when an Checkpoint Therapeutics, Inc. insider buys or sells CKPT shares.

Notify only if

News

Receive news related to Checkpoint Therapeutics, Inc.

Track Activities on CKPT